Gillespie Borate

Hazard statements (CLP)

H350

Code

Statements

H350

May cause cancer

SECTION 2: Hazards identification

NFPA Rating Classification of the substance or mixture d~  GHS08 Health hazard Carc. 1A H350 May cause cancer (inhalation) Additional information A trade secret component in this proprietary formulation is classified by IARC as a carcinogen upon repeated inhalative exposure

2.2 Label elements

· GHS label elements The product is classified and labeled according to the Globally Harmonized System (GHS). · Hazard pictograms: ~dGHS08

Signal word

Danger

Hazardous Ingredients

Trade Secret

Hazard statements

H350 May cause cancer (inhalation) · Issue date 08/02/2016 · Date of preparation / last revision 08/21/2023 Trade name: Gillespie Borate

Precautionary statements

P280 Wear protective gloves/protective clothing/eye protection/face protection. P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P308+P313 IF exposed or concerned: Get medical advice/attention. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations. ·Unknown acute toxicity: 9.9 % of the mixture consists of component(s) of unknown toxicity.

Classification system

· NFPA ratings (scale 0 - 4) Health = 1 slightly hazardous Fire = 0 will not burn Reactivity = 0 stable · HMIS-ratings (scale 0 - 4) Health = 1 irritation possible Fire = 0 will not burn Reactivity = 0 stable

2.3 Other hazards

None known

2.1 Classification of the substance or mixture

d~  GHS08 Health hazard Carc. 1A H350 May cause cancer (inhalation). Additional information: A trade secret component in this proprietary formulation is classified by IARC as a carcinogen upon repeated inhalative exposure.